Toripalimab-based Neoadjuvant Therapy in LA-HNSCC
Clinical trial NCT05522985 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05522985
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2023-12-07
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.